Friday, Sep 29, 2023
English News
  • Hyderabad
  • Telangana
  • AP News
  • India
  • World
  • Entertainment
  • Science and Tech
  • Sport
  • Business
  • Rewind
  • ...
    • NRI
    • View Point
    • cartoon
    • Columns
    • Education Today
    • Reviews
    • Property
    • Videos
    • Lifestyle
E-Paper
  • NRI
  • View Point
  • cartoon
  • Columns
  • Reviews
  • Education Today
  • Property
  • Videos
  • Lifestyle
Home | Business | Dr Reddys Collaborates With Four Pharma Companies For Molnupiravir Trial

Dr Reddy’s collaborates with four pharma companies for molnupiravir trial

On successful completion of the clinical trial, each company will independently approach the regulatory authorities for approval to manufacture and supply the drug for the treatment of Covid-19 in India

By Telangana Today
Published Date - 05:03 PM, Tue - 29 June 21
Dr Reddy’s collaborates with four pharma companies for molnupiravir trial
whatsapp facebook twitter telegram

Hyderabad: Hyderabad-based Dr Reddy’s Laboratories has collaborated with other pharma companies such as Cipla, Emcure Pharmaceuticals, Sun Pharmaceutical Industries and Torrent Pharmaceuticals for the clinical trial of the investigational oral anti-viral drug molnupiravir for the treatment of mild Covid-19 in an outpatient setting in India.

Between March and April this year, these five pharma companies had individually entered into a non-exclusive voluntary licensing agreement with Merck Sharp Dohme (MSD) to manufacture and supply molnupiravir to India and over 100 low and middle-income countries (LMICs).

The five pharma companies have entered into a collaboration agreement, wherein the parties will jointly sponsor, supervise and monitor the clinical trial in India.

As per the directive of the Subject Expert Committee (SEC) of the Central Drugs Standard Control Organization, Dr Reddy’s will conduct the clinical trial using its product, and the other four pharma companies will be required to demonstrate equivalence of their product to the product used by Dr Reddy’s in its clinical trial.

Following the clinical trial protocol approval given by the Drugs Controller General of India (DCGI), the clinical trial will be conducted for the treatment of mild Covid-19 in an outpatient setting. The trial is expected to take place between June and September this year across India with the recruitment of 1,200 patients.

Such collaboration for a clinical trial is a first-of-its-kind within the Indian pharma industry and will aim to investigate yet another line of treatment in the collective fight against the Covid-19 pandemic. On successful completion of the clinical trial, each company will independently approach the regulatory authorities for approval to manufacture and supply molnupiravir for the treatment of Covid-19 in India.

Molnupiravir is an oral anti-viral that inhibits the replication of multiple RNA viruses including SARS-CoV-2. It is presently being studied by MSD, through a collaboration with Ridgeback Biotherapeutics, in a phase III trial for the treatment of non-hospitalised patients with confirmed Covid-19 globally.


Now you can get handpicked stories from Telangana Today on Telegram everyday. Click the link to subscribe.

Click to follow Telangana Today Facebook page and Twitter .


Telangana Today Whatsapp
  • Follow Us :
  • Tags
  • Covid-19
  • Dr Reddy’s Laboratories
  • Dr.Reddy's
  • Molnupiravir

Related News

  • Wife’s efforts to meet expenses no ground to reduce maintenance amount by husband: Delhi HC

    Wife’s efforts to meet expenses no ground to reduce maintenance amount by husband: Delhi HC

  • China propels Apple’s growth in last 9 years, net sales up by 128%: Report

    China propels Apple’s growth in last 9 years, net sales up by 128%: Report

  • Memorial for journalists killed during COVID-19 to be inaugurated on October 2

    Memorial for journalists killed during COVID-19 to be inaugurated on October 2

  • India records 40 fresh Covid-19 cases on Monday

    India records 40 fresh Covid-19 cases on Monday

  • India reports 70 new Covid-19 cases

    India reports 70 new Covid-19 cases

  • Opinion: Why slowing China worries West

    Opinion: Why slowing China worries West

Latest News

  • End your job search with DEET

    10 mins ago
  • Cauvery water row: Karnataka CM Siddaramaiah holds meeting with retired judges of Supreme Court, irrigation experts

    18 mins ago
  • Kerala: IMD sounds yellow alert in all districts

    33 mins ago
  • Bangladesh beat Sri Lanka by seven wickets in World Cup warm-up match

    58 mins ago
  • Royal Air Force jets make refuelling stop at RGIA

    1 hour ago
  • BRAOU implements smart certificate printing for faster delivery

    1 hour ago
  • Hyderabad sees 60% surge in housing supply

    1 hour ago
  • Centre’s disparity in Grant-in-aid funds to Telangana

    2 hours ago

company

  • Home
  • About Us
  • Contact Us

business

  • Subscribe

telangana today

  • Telangana
  • Hyderabad
  • Latest News
  • Entertainment
  • World
  • Andhra Pradesh
  • Science & Tech
  • Sport

follow us

© Copyrights 2022 TELANGANA PUBLICATIONS PVT. LTD. All rights reserved. Powered by Veegam